LENSGEN HITTING MILESTONES AND BROADENING PATENT PROTECTION

LENSGEN ANNOUNCED ADDITIONAL FINANCING AND PATENT GRANTS.

ExSight portfolio company LensGen announced additional financing and patent grants. LensGen is developing the world's first modular, fluid-optic, curvature changing intraocular lens ("IOL"). LensGen “achieved a key clinical performance milestone which triggered the release of $11 million in funding as part of the Series A Financing.” HOYA, the lead investor, also exercised an option to invest an additional $4.4M under the terms of the Series A financing. In the same period, the US Patent Office granted LensGen two new patents that give the company comprehensive protection of its technology. The additional funding will take the Company closer to bringing the Juvene platform to market.

We're very proud to be a part of the Company's journey. Congratulations to the LensGen team!

Full Press Release